Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada

Kyle A Thompson,Gabriel Blank,Junine Toy,David M Moore,Nathan Lachowsky,Nicanor Bacani,Wendy Zhang,Paul Sereda,Viviane D Lima,Rolando Barrios,Julio S G Montaner,Mark W Hull

OPEN FORUM INFECTIOUS DISEASES（2021）

引用 1|浏览2

暂无评分

摘要

Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.

查看译文

关键词

emtricitabine, tenofovir disoproxil fumarate, hepatitis B, HIV PrEP, HIV prevention, MSM

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要